New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease
Alzheimer's disease (AD) is the most common progressive form of brain neurodegeneration and the most prevailing cause of dementia. Unfortunately, the aetiology of AD is not completely studied but different factors are associated with the development of AD such as among others low level of acety...
Saved in:
Main Authors: | Kamila Czarnecka (Author), Małgorzata Girek (Author), Karolina Maciejewska (Author), Robert Skibiński (Author), Jakub Jończyk (Author), Marek Bajda (Author), Jacek Kabziński (Author), Przemysław Sołowiej (Author), Ireneusz Majsterek (Author), Paweł Szymański (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease
by: Kamila Czarnecka, et al.
Published: (2023) -
Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease
Published: (2018) -
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
by: Luca Piemontese, et al.
Published: (2018) -
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease
by: Lidia Ciccone, et al.
Published: (2023) -
New multifunctional compounding mixer.
by: Aldona Maciejewska, et al.
Published: (2021)